Job Title: Postdoctoral Researcher: Prescribing and Medicines Optimisation
Department: School of Pharmacy and Biomolecular Sciences
Reporting to: Dr Frank Moriarty
Location: RCSI University of Medicine and Health Sciences, Dublin 2
Contract/Duration: Up to 5 years (depending on start date)
Remuneration: €50,540 per year (IUA Scale PD2 Pt 1 - annual increments will apply)
Closing Date: March 3rd 2024
Starting Date: As soon as possible
Summary of Post
The SYNERG-IE Programme is an ambitious five-year programme supported by a €2.5m Applied Programme Grant (APRO) award from the Health Research Board in Ireland. Projects funded under this programme are designed to have an impact on the health and social care of individuals, population health, and the health system in Ireland and beyond.
SYNERG-IE is a multidisciplinary research programme designed in partnership with Sjögren's Ireland that aims to address longstanding challenges in the recognition, diagnosis, and management of Sjögren's (pronounced ‘show- grins'). Sjögren's is a chronic autoimmune disease affecting approximately 1 in 200 people that is associated with significant morbidity affecting quality of life. Although relatively common, its complexity means that early signs and symptoms are often missed, leading to delays in diagnosis of ten years or longer for many people.
This programme will adopt a collaborative and inclusive approach, combining the skills of multidisciplinary researchers, the insights of patients, and the needs of healthcare professionals and policymakers to bring about transformative change in Sjögren's care and research. Through involving people living with Sjögren's and healthcare professionals, the research will reflect the real-world experiences of Sjögren's and the findings will have maximum impact, leading to tangible improvements in care.
The SYNERG-IE Programme aims to make a difference to the lives of people affected by Sjögren's in many ways. By optimising prescribing practices and medicines use, people will experience more personalised and effective treatments. Co-design approaches will be used to develop improved care pathways to enhance care experiences. National guidance and policies will provide a clear framework for care, reducing the current delays in diagnosis and treatment. Furthermore, the increased knowledge stemming from undergraduate and postgraduate education initiatives will improve awareness.
We want to recruit a postdoctoral researcher who will primarily focus on research relating to prescribing and medicines optimisation to enhance Sjögren's care. This will involve analysis of primary care patient record data from the UK (to examine care and prescribing both before and after individuals are diagnosed with Sjögren's), collection and analysis of survey data in Ireland, including data on medications used, and contributions to other areas of the programme.
Specifically, the duties of the post will be:
Qualifications – (Essential):
Knowledge & Experience – ( Essential):
Knowledge & Experience – ( Desirable):
We are all too aware that imposter syndrome and the confidence gap can sometimes stop fantastic candidates putting themselves forward, so please do submit an application — we'd love to hear from you. #rcsiar
Please apply online through the RCSI careers portal on the closing date with your CV and cover letter.
Informal Enquiries can be directed to [email protected]. Please note we do not accept CVs directly.